Applications published 21 November 2007

Diiodomethyl-p-tolylsulphone as a particulate dispersion in a liquid solvent
Procter & Gamble 1855646*

• Delayed release pharmaceutical oral dosage form and method of making same
Intelgenx 1855647*

• Topical stabilised prostaglandin E compound dosage forms
Nexmed Holdings 1855648*

• Method of treating atherosclerosis, dyslipidemias and related conditions
Merck & Co 1855649*

• Aqueous topical gel of high stability based on metronidazole and method of preparation
Galderma 1855650*

• Nanoparticulate compsns of heterocyclic amide derivatives
Elan Pharma International 1855651*

• Drying of drug-containing particles
Pfizer Products 1855652*

• Compsn for oral application with controlled release of active substances
Maria Clementine Martin Klosterfrau Vetriebsgesellschaft 1855653*

• Tablets comprising a high load of strontium
Osteologix 1855654*

• Tablets with improved drug substance dispersability
F Hoffmann-La Roche 1855655*

• Orally bioavailable CCI-799 tablet formulations
Wyeth 1855656*

• Dosage form containing oxycodone and naloxone
Euro-Celtique 1855657*

• Compsns comprising entrained water and agents entrained in water-sensitive matrices
Mary Kay 1855658*

• Nanoparticulate formulations of docetaxel and analogues thereof
Elan Pharma International 1855659*

• Non-fibrous transdermal therapeutic system and method for its production
LTS Lohmann Therapie-Systeme 1855660*

• Formation for aviptadil
MondoBIOTECH Licencing Out 1855661*

• Methods and compsns for treating cancer
Sound Pharmaceuticals 1855662*

• Methods for modulating macrophage proliferation in ocular disease using polyamine analogues
Pathologica 1855663*

• Mitotic kinesin inhibitors
Merck & Co 1855664*

• Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (VHL) disease
Burzynski, Stanislaw 1855665*

• Dronabinol compsns and methods of using same
Unimed Pharmaceuticals 1855666*

• Pharmaceutical compsn comprising an indolylmaleimide derivative
Novartis 1855667*

• Novel method for obtaining a fast-dissolving imidapril powder
Sa Vetoquinol 1855668*

• Liposomal compsns for parenteral delivery of agents
BC Cancer Agency; University Health Network 1855669*

• Benzazole potentiators of metabotropic glutamate receptors
Merck & Co 1855670*

• Oral dosage form comprising rosiglitazone
SB Pharmco Puerto Rico 1855671*

• HIV Protease inhibitors
SmithKline Beecham 1855672*

• Drug combination therapy and pharmaceutical compsns for treating inflammatory disorders
Merck & Co 1855673*

• Compsn for inhibition of cathepsin K
Merck & Co 1855674*

• Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases
Sanofi-Aventis 1855675*

• Tetracyclic amino and carboxamido compounds and methods of use thereof
Inotek Pharmaceuticals 1855676*

• 3,11B cis dihydrotetrabanzine for the treatment of schizophrenia and other psychoses
Cambridge Laboratories (Ireland) 1855677*

• Use of 3-substitutyed-2-(diphenyl-methyl)-1-azabicyclo 2.2.2 octanes for treating MRG-X1 receptor mediated diseases
Merck & Co 1855678*

• Aminomethyl beta-secretase inhibitors for the treatment of Alzheimer's disease
Merck & Co 1855679*

• Method of treatment of diarrhoea-predominant IBS in a female subject receiving contraceptive therapy
Solvay Pharmaceuticals 1855680*

• Method of treatment of diarrhoea-predominant irritable bowel syndrome in a subject
Solvay Pharmaceuticals 1855681*

• Aminopterin dosage forms and methods for inflammatory disorders
Syntrix Biosystems 1855682*

• A solid pharmaceutical dosage formulation
Abbott Laboratories 1855683*

• Pharmaceutical compsns of the isolated D-enantiomer of the quinazolinone derivative halofuginone
Collgard Biopharmaceuticals 1855684*

• Mitotic kinesin inhibitors
Merck & Co 1855685*

• Use of PDE7 inhibitors for the treatment of neuropathic pain
Pfizer 1855686*

• Medicament forms with controlled bioavailability
Bayer Healthcare 1855687*